AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33237229 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealer 26
Number of subjects: 54
Study 33237229 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 54
Study 33922929 — intervention group
Group type: EXPERIMENTAL
Intervention: Team emotional management intervention designed to help detect and manage emotions during virtual teamwork
Number of subjects: 102
Study 33922929 — intervention group
Group type: COMPARATOR
Intervention: Control condition (with no intervention)
Number of subjects: 102
Study 32371432 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordant to disease activity cluster
Number of subjects: 140
Study 32371432 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant fatigue cluster
Number of subjects: 140
Study 32371432 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant pain and fatigue cluster
Number of subjects: 140
Study 32371432 — intervention group
Group type: COMPARATOR
Intervention: Concordant cluster vs Dominant pain and fatigue cluster
Number of subjects: 140
Study 32371432 — intervention group
Group type: COMPARATOR
Intervention: Concordant cluster vs Dominant fatigue cluster
Number of subjects: 140
Study 32371432 — intervention group
Group type: COMPARATOR
Intervention: Other PROs
Number of subjects: 140
Study 32045540 — intervention group
Group type: EXPERIMENTAL
Intervention: New clinical V̇O2 peak equation from 6MWT: V̇O2 peak (mL.kg‐1.min‐1) = (‐0.283*age(years)) ‐ (0.099*weight(kg)) + (0.071*6MWD(meters)) ‐(0.135*HR end(bpm)) + 22.789
Number of subjects: 200
Study 32045540 — intervention group
Group type: EXPERIMENTAL
Intervention: New disease-specific V̇O2 peak equation from 6MWT: V̇O2 peak (mL.kg‐1.min‐1) = (‐0.236*age(years)) ‐ (0.094*weight(kg)) ‐(0.120*HR end(bpm)) + (0.067*6MWD(meters)) + (0.065*MVLPA(min/day)) ‐ (0.204*DT(years)) + 25.145
Number of subjects: 200
Study 32852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian methods
Number of subjects: 0
Study 32852275 — intervention group
Group type: COMPARATOR
Intervention: Statistical significance testing
Number of subjects: 0
Study 34275774 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug holiday from 1 month before to 3 months after surgical tooth extraction
Number of subjects: 23
Study 34275774 — intervention group
Group type: COMPARATOR
Intervention: Drug continuation
Number of subjects: 23
Study 33848565 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, moderate-intensity physical activity intervention (PA)
Number of subjects: 1535
Study 33848565 — intervention group
Group type: COMPARATOR
Intervention: Health education program (HE)
Number of subjects: 1535
Study 34853162 — intervention group
Group type: EXPERIMENTAL
Intervention: CLO view
Number of subjects: 100
Study 34853162 — intervention group
Group type: COMPARATOR
Intervention: LAT view
Number of subjects: 100
Study 32594244 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed ramp test
Number of subjects: 21
Study 32594244 — intervention group
Group type: COMPARATOR
Intervention: Unprimed ramp test
Number of subjects: 21
Study 32594244 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ramp tests
Number of subjects: 21
Study 34949526 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 95
Study 34949526 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 95
Study 34283893 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored messaging (TM+)
Number of subjects: 149
Study 34283893 — intervention group
Group type: COMPARATOR
Intervention: Targeted messaging (TM)
Number of subjects: 149
Study 35893914 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligomeric hyperproteic normocaloric (OHN) supplement
Number of subjects: 151
Study 35893914 — intervention group
Group type: COMPARATOR
Intervention: Immunonutritional (IN) supplement
Number of subjects: 151
Study 35791877 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine during baseline night (BN)
Number of subjects: 12
Study 35791877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg of caffeine during total sleep deprivation (TSD)
Number of subjects: 12
Study 35791877 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine during BN
Number of subjects: 12
Study 35791877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg of caffeine during TSD
Number of subjects: 12
Study 35791877 — intervention group
Group type: COMPARATOR
Intervention: Placebo during BN
Number of subjects: 12
Study 35791877 — intervention group
Group type: COMPARATOR
Intervention: Placebo during TSD
Number of subjects: 12
Study 34116206 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively Smoke Free Video-Groups
Number of subjects: 0
Study 34116206 — intervention group
Group type: COMPARATOR
Intervention: Healthy Relationship Video-Groups (Control)
Number of subjects: 0
Study 34116206 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Positively Smoke Free and Healthy Relationship)
Number of subjects: 0
Study 33072373 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutritional counselling and physical activity training
Number of subjects: 66
Study 35015903 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (MTX)
Number of subjects: 77
Study 35015903 — intervention group
Group type: COMPARATOR
Intervention: Oral methotrexate (MTX)
Number of subjects: 77
Study 35015903 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 77
Study 33499510 — intervention group
Group type: EXPERIMENTAL
Intervention: CBTIweb.org
Number of subjects: 41
Study 33499510 — intervention group
Group type: COMPARATOR
Intervention: In-person workshop
Number of subjects: 41
Study 34320100 — intervention group
Group type: EXPERIMENTAL
Intervention: Phakic patients
Number of subjects: 40
Study 34320100 — intervention group
Group type: COMPARATOR
Intervention: Pseudophakic patients
Number of subjects: 40
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare service use (hospitalisations, mental health and regular emergency department visits, outpatient visits)
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department visits
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial barriers (resources and health insurance)
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Social functioning score
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of schizophrenia
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health scores (Medical Outcomes Study 36-item Short Form Health Survey)
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dependence
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Being ‘absolutely homeless’
Number of subjects: 671
Study 32679400 — intervention group
Group type: EXPERIMENTAL
Intervention: Homelessness trajectory factors
Number of subjects: 671
Study 36404301 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 557
Study 36404301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 557
Study 35803643 — intervention group
Group type: EXPERIMENTAL
Intervention: Art-based intervention with five visual thinking activities
Number of subjects: 94
Study 34671412 — intervention group
Group type: EXPERIMENTAL
Intervention: ImmuActive
Number of subjects: 100
Study 34671412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35165769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided genicular nerve block (GNB)
Number of subjects: 102
Study 35165769 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 102
Study 32898578 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 601
Study 32898578 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 601
Study 33187677 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic Surfactant CHF5633
Number of subjects: 0
Study 33187677 — intervention group
Group type: COMPARATOR
Intervention: Poractant Alfa
Number of subjects: 0
Study 35836924 — intervention group
Group type: EXPERIMENTAL
Intervention: 5E rehabilitation nursing model
Number of subjects: 60
Study 34456042 — intervention group
Group type: EXPERIMENTAL
Intervention: Real SNAG group
Number of subjects: 30
Study 34456042 — intervention group
Group type: COMPARATOR
Intervention: Sham SNAG group
Number of subjects: 30
Study 33664449 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil count
Number of subjects: 173480
Study 33664449 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil percentage of white cells
Number of subjects: 173480
Study 33664449 — intervention group
Group type: COMPARATOR
Intervention: HBC traits
Number of subjects: 173480
Study 32078436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa beverage (15 g of cocoa and 75 mg of epicatechin daily)
Number of subjects: 44
Study 32078436 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (identical appearance, contained neither cocoa nor epicatechin)
Number of subjects: 44
Study 36194164 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg, oral daily for a maximum of 1 year)
Number of subjects: 52
Study 36194164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33983634 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group receiving six supervised functional training sessions of 10 min each
Number of subjects: 20
Study 33983634 — intervention group
Group type: COMPARATOR
Intervention: Control group without training
Number of subjects: 20
Study 32167494 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral central venous catheter insertion site
Number of subjects: 7235
Study 32167494 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral arterial catheter insertion site
Number of subjects: 7235
Study 32167494 — intervention group
Group type: COMPARATOR
Intervention: Nonfemoral central venous catheter insertion site
Number of subjects: 7235
Study 32167494 — intervention group
Group type: COMPARATOR
Intervention: Nonfemoral arterial catheter insertion site
Number of subjects: 7235
Study 35704561 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog-assisted interventions
Number of subjects: 0
Study 35704561 — intervention group
Group type: COMPARATOR
Intervention: Relaxation intervention
Number of subjects: 0
Study 35704561 — intervention group
Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 0
Study 33038018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load RT to failure (HLF, n = 11, 75% of 1RM, three sets to failure)
Number of subjects: 42
Study 33038018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load RT without failure (HLNF, n = 11, 75% of 1RM, six sets of five repetitions)
Number of subjects: 42
Study 33038018 — intervention group
Group type: COMPARATOR
Intervention: Low-load RT to failure (LLF, n = 11, 25% of 1RM, three sets to failure)
Number of subjects: 42
Study 33038018 — intervention group
Group type: COMPARATOR
Intervention: Control (CON, n = 9)
Number of subjects: 42
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan-prednisone-lenalidomide followed by lenalidomide maintenance (MPR-R)
Number of subjects: 168
Study 33351127 — intervention group
Group type: COMPARATOR
Intervention: melphalan-prednisone-thalidomide followed by thalidomide maintenance (MPT-T)
Number of subjects: 168
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: SKY-RISS I (SKY-SR 1 R-ISS-I)
Number of subjects: 168
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: SKY-RISS II (all other patients)
Number of subjects: 168
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: SKY-RISS III (SKY-HR 1 R-ISS-II/III)
Number of subjects: 168
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: SKY92 classifier
Number of subjects: 168
Study 33351127 — intervention group
Group type: EXPERIMENTAL
Intervention: R-ISS
Number of subjects: 168
Study 36271422 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved housing modifications as part of the RooPfs trial
Number of subjects: 391
Study 36271422 — intervention group
Group type: EXPERIMENTAL
Intervention: Local perceptions of a good house
Number of subjects: 391
Study 36271422 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term relationship with the implementing institution
Number of subjects: 391
Study 33812488 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed strategy (RRT started just after randomisation)
Number of subjects: 278
Study 33812488 — intervention group
Group type: COMPARATOR
Intervention: More-delayed strategy (RRT initiation postponed until mandatory indication or blood urea nitrogen concentration reached 140 mg/dL)
Number of subjects: 278
Study 33812488 — intervention group
Group type: COMPARATOR
Intervention: More-delayed strategy
Number of subjects: 278
Study 33812488 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 278
Study 34980050 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position lumbar puncture
Number of subjects: 0
Study 34980050 — intervention group
Group type: COMPARATOR
Intervention: Lateral decubitus position lumbar puncture
Number of subjects: 0
Study 34326178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting intervention (32.7 visits by family midwives and/or social pedagogues until child age 2 years)
Number of subjects: 755
Study 32671719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib (Cabometyx®)
Number of subjects: 0
Study 32671719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35319832 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitogel
Number of subjects: 25
Study 36116104 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple HOPES (online couple intervention for PTSD)
Number of subjects: 27
Study 33568230 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally applied gentamicin
Number of subjects: 0
Study 33568230 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0
Study 33285624 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused shock wave therapy (FSWT)
Number of subjects: 55
Study 33285624 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy (RSWT)
Number of subjects: 55
Study 35999526 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP + FB (Group PF)
Number of subjects: 198
Study 35999526 — intervention group
Group type: COMPARATOR
Intervention: PVP (Group P)
Number of subjects: 198
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic corrective exercises for 12 weeks
Number of subjects: 30
Study 34912505 — intervention group
Group type: COMPARATOR
Intervention: Routine exercise (control group)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Static balance (Flamingo balance test)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Static balance (stabilometr)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance (star excursion balance test - anterior direction)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance (star excursion balance test - posterior-internal direction)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance (star excursion balance test - posterior-external direction)
Number of subjects: 30
Study 34912505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance (stabilometr)
Number of subjects: 30
Study 33272026 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based self-management intervention
Number of subjects: 500
Study 32451161 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapist‐led exercise and education program for 12 weeks
Number of subjects: 0
Study 32451161 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention
Number of subjects: 0
Study 35379064 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg twice daily for 2 weeks)
Number of subjects: 50
Study 34107836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5C1E (5s concentric action and 1s eccentric action)
Number of subjects: 40
Study 34107836 — intervention group
Group type: EXPERIMENTAL
Intervention: 3C3E (3s concentric action and 3s eccentric action)
Number of subjects: 40
Study 34107836 — intervention group
Group type: EXPERIMENTAL
Intervention: 1C5E (1s concentric action and 5s eccentric action)
Number of subjects: 40
Study 34107836 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 32196749 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 959 (300 mg IV infusion)
Number of subjects: 0
Study 32196749 — intervention group
Group type: COMPARATOR
Intervention: Eculizumab US (FDA-licensed)
Number of subjects: 0
Study 32196749 — intervention group
Group type: COMPARATOR
Intervention: Eculizumab EU (EU-authorized)
Number of subjects: 0
Study 33128537 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert consensus on diagnostic standard and syndrome types for palpitations below the heart.
Number of subjects: 19
Study 33128537 — intervention group
Group type: EXPERIMENTAL
Intervention: Main diagnoses identified in TCM for palpitations below the heart.
Number of subjects: 19
Study 33128537 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary diagnosis identified in TCM for palpitations below the heart.
Number of subjects: 19
Study 33128537 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM syndrome differentiation for palpitations below the heart.
Number of subjects: 19
Study 33128537 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability of expert opinions in the consultation process.
Number of subjects: 19
Study 32496922 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐printed PCNL model (Group B)
Number of subjects: 40
Study 32496922 — intervention group
Group type: COMPARATOR
Intervention: URO Mentor™ surgical simulator (Group A)
Number of subjects: 40
Study 35400328 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (97/103 mg once or twice daily)
Number of subjects: 502
Study 35400328 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan (40 mg once or twice daily)
Number of subjects: 502
Study 34144432 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting training intervention
Number of subjects: 280
Study 32406858 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based self-management intervention
Number of subjects: 1193
Study 32406858 — intervention group
Group type: COMPARATOR
Intervention: Paper-based observational follow-up study
Number of subjects: 1193
Study 35088556 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 0
Study 35088556 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive deep brain stimulation (rDBS)
Number of subjects: 0
Study 35088556 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness threshold for rDBS
Number of subjects: 0
Study 33038096 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (polyphenols, omega-3, vitamin E, selenium)
Number of subjects: 20
Study 33038096 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (control)
Number of subjects: 20
Study 35614523 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention for dual users of combustible and electronic cigarettes
Number of subjects: 2706
Study 33509129 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone (10 mg three times per day)
Number of subjects: 48
Study 33509129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32744483 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-recorded hypnosis intervention
Number of subjects: 97
Study 32744483 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological treatment and usual physical or psychological activities
Number of subjects: 97
Study 35065003 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 223
Study 35065003 — intervention group
Group type: COMPARATOR
Intervention: RFA
Number of subjects: 223
Study 33387931 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Valsalva manoeuvre
Number of subjects: 11
Study 33387931 — intervention group
Group type: COMPARATOR
Intervention: Modified Valsalva manoeuvre
Number of subjects: 11
Study 35363345 — intervention group
Group type: EXPERIMENTAL
Intervention: Trampoline-based stretch-shortening cycle (SSC) exercises
Number of subjects: 32
Study 36172511 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS training program
Number of subjects: 0
Study 35870990 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine hydrochloride injection
Number of subjects: 3000
Study 35870990 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without S(+)‐ketamine
Number of subjects: 3000
Study 33783089 — intervention group
Group type: EXPERIMENTAL
Intervention: Frankfort Mandibular Plane Angle (FMA) as a diagnostic test
Number of subjects: 0
Study 33783089 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trials related to FMA
Number of subjects: 0
Study 32700393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 or 15 mg)
Number of subjects: 0
Study 32700393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35460601 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg once daily)
Number of subjects: 464
Study 35460601 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted darunavir (800 mg of darunavir plus 100 mg of ritonavir once daily)
Number of subjects: 464
Study 35460601 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir (300 mg once daily) plus lamivudine (300 mg once daily)
Number of subjects: 464
Study 35460601 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (300 mg twice daily) plus lamivudine (150 mg twice daily)
Number of subjects: 464
Study 35460601 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 464
Study 32950597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lugol-unstained lesions (LULs) size >5 mm
Number of subjects: 1058
Study 32950597 — intervention group
Group type: COMPARATOR
Intervention: Lugol-unstained lesions (LULs) size ≤5 mm
Number of subjects: 1058